Nextgen Share Discussion Threads

[stephanie_m] 13/4/2011 07:51

Expected to open up 32%+

s

[lady gaga] 13/4/2011 07:49

Annual report due this month

So more news due soon.

I like this bit

Klaus Rosenau, Chairman and CEO of NextGen Group, commented, 'The release of plasmabreast25 is further indication of our commitment to developing and marketing multiplex assays for biomarker discovery in specific cancer areas. It enables us to remain focused on increasing our market share from the $600m mass spectrometry based biomarker discovery market. To ensure we continually deliver the high-quality assays that pharmaceutical, biotechnology and diagnostics companies need to inform their decision-making processes, NextGen Sciences is currently planning more such products in the near future.'

More in the near future so more days like this soon.

No braner

[sonicx] 13/4/2011 07:32

This looks like great news, onwards and upwards to that 1p mark I say!

[lady gaga] 13/4/2011 07:32

Someone likes it were up 32% pre open.

Its earley days yet.

GLTA

[bobby.ifa] 13/4/2011 07:10

Not sure how to re-act to this, however, I suppose it create interest & elivate's NNG product offering & activity. Will cost money though.

13 April 2011

NextGen Sciences

NextGen Sciences launches multiplex protein plasma biomarker assay for breast cancer

Ann Arbor, Michigan, US, and London, UK, 13 April 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its plasmabreast25 multiplex protein assay, targeting breast cancer biomarker discovery and qualification. The assay simultaneously measures 25 human plasma proteins that are thought to have potential as biomarkers in breast cancer.

Klaus Rosenau, Chairman and CEO of NextGen Group, commented, 'The release of plasmabreast25 is further indication of our commitment to developing and marketing multiplex assays for biomarker discovery in specific cancer areas. It enables us to remain focused on increasing our market share from the $600m mass spectrometry based biomarker discovery market. To ensure we continually deliver the high-quality assays that pharmaceutical, biotechnology and diagnostics companies need to inform their decision-making processes, NextGen Sciences is currently planning more such products in the near future.'

NextGen's assay is based upon its multiple reaction monitoring (MRM) mass spectrometry platform and generates high quality reproducible data that companies can use in their drug and diagnostic development programmes. NextGen expects to develop further oncology and CNS disease-focused assay panels, both as proprietary products and with other companies, through partnerships and collaborations.

- ENDS -

For more information please contact :

NextGen Group

Klaus Rosenau, Chairman and CEO

[e-mail]

[phone]

Seymour Pierce

Jonathan Wright, Nicola Marrin

[phone]

[moochy] 12/4/2011 18:22

what! PRM?? I'm sure you're on drugs Doc.

[the_doctor] 12/4/2011 16:01

Doubt it - this doesnt have the big value driver potential that PRM has IMO

I'll be interested to see how it fares though

[moochy] 12/4/2011 14:32

That would be great LG. but I'm hoping for 1.5p short term.

[lady gaga] 11/4/2011 13:58

Id be happy with 1p myself.

[moochy] 11/4/2011 11:53

Not many sellers here. A solid RNS will send this share price to the moon.

[stephanie_m] 10/4/2011 09:50

Annual report due this month.
s

[moochy] 06/4/2011 21:46

Lokesh8, can you tell me where you have obtained this info?

[lokesh8] 06/4/2011 17:59

Settlement as of 06/04/2011, at 5:45 p.m.

Nextgen Group Plc settles around previous levels, slipping 0.00% at close of trade. The share started the day in neutral territory, and continued to move sideways during the session, before finally perking up to finish at 0.34, the day's highest price. On a weekly basis, the stock is trending higher than the UK FTSE All Share. For the moment, therefore, Nextgen Group Plc clearly appeals more to investors than the benchmark.
Status and Trend Analysis

While the medium-term picture confirms Nextgen Group Plc's negative trend, the short term reveals the possibility of a timid upswing to first resistance in the 0.3533 area. First support is identified at 0.3133. Further positive cues could signal an upward movement with a target of 0.3933.
Risk Analysis

The Nextgen Group Plc stock's level of risk turns out to be fairly high as prices have recently been deviating widely. The stock would therefore suit investors who, in their pursuit of big gains, are well aware that they also risk large losses. Daily volume is subdued at 1,114,077, below the 1-month moving average for volume of 3,831,723.

Resistance 2 0.3933
Resistance 1 0.3533
Closing price 0.34
Support 1 0.3133
Support 2 0.2867
Volatility (daily) 28.64
Value At Risk % 66.62
Performance (weekly) 14.14 %
UK FTSE All Share (weekly) 1.19 %
Performance (yearly) 100.00 %

[lokesh8] 05/4/2011 18:40

Settlement as of 05/04/2011, at 5:45 p.m.

A flat performance from Nextgen Group Plc, which edges down 0.00%. The security opened on a par with the previous close and showed considerable stability throughout trading, before closing uptrend near its high of 0.347. Nextgen Group Plc's weekly trend is more sluggish than the benchmark's movements. The downswing could create selling opportunities for Nextgen Group Plc stock.
Status and Trend Analysis

Although the medium-term outlook for Nextgen Group Plc remains negative, we find an increasing upward movement in the short term, with the most immediate resistance at 0.3533. Support is at 0.3133. The technicals favour a new upswing to the 0.3933 area.
Risk Analysis

With a daily volatility of 28.72 the Nextgen Group Plc share has primarily caught the attention of risk-loving investors. Trading opportunities should primarily be sought in a short-term perspective, as the intraday volume of 731,308 is below the volume moving average of 3,799,582 for the last month.

Resistance 2 0.3933
Resistance 1 0.3533
Closing price 0.34
Support 1 0.3133
Support 2 0.2867
Volatility (daily) 28.72
Value At Risk % 66.81
Performance (weekly) -0.16 %
UK FTSE All Share (weekly) 1.76 %
Performance (yearly) 100.00 %

[moochy] 05/4/2011 08:59

Stephanie, MMs want to buy more shares for themselves so they require sellers not buyers.

[moochy] 05/4/2011 08:50

what a silly spread 21%. MMs obviously discouraging buyers.

[stephanie_m] 04/4/2011 20:18

If the MM s do not want buyers, what message is this giving to PI's

I do not quite understand the point you are making.

[sonicx] 04/4/2011 19:16

Stephanie_M:

Its obvious they don't want buyers because the spread was huge all day long

[lady gaga] 04/4/2011 17:49

Ticked back up b 4 close.

We may have a good week here yet.

[stephanie_m] 04/4/2011 14:55

I continue to steadly build up my holding at under .40p

s

[stephanie_m] 04/4/2011 14:55

sonicx - 4 Apr'11 - 13:58 - 90 of 91 (premium)


"They are just trying to discourage buying thats all"


Why would you think that sonicx?

s

[lady gaga] 04/4/2011 14:03

Just sit tight on the shares guys.

They want them but thell bloody have to pay for them.

Only 15% of shares in issue.

So this can move rly fast.

GLTA

LG

[sonicx] 04/4/2011 13:58

They are just trying to discourage buying thats all, but sometimes they get overwhelmed and have to raise both OFFER and BID

[lady gaga] 04/4/2011 13:58

id say so was .7p a few weeks ago

[sonicx] 04/4/2011 13:56

Should be at 0.5p within the hour at this rate?